Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
01/2013
01/01/2013US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343913 Hsp90, buffering and drug resistance
01/01/2013US8343549 Therapeutic uses of Dunaliella powder
01/01/2013US8343543 Lipase inhibiting composition
01/01/2013US8343508 Botulinum antitoxin compositions and methods
01/01/2013US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family
01/01/2013US8343476 Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B
01/01/2013US8343475 Small cationic antimicrobial peptides
12/2012
12/27/2012WO2012176804A1 Glucopyranosyloxypyrazole derivative
12/27/2012WO2012176651A1 Novel anti-tumor agent, and method for screening for novel anti-tumor agent
12/27/2012WO2012176282A1 Apoptosis-inducing agent
12/27/2012WO2012176149A1 Treatment of hepatitis c virus
12/27/2012WO2012175973A1 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
12/27/2012WO2012175659A1 N-acetyl cysteine and composition thereof for use in the treatment of vaginal pathologies
12/27/2012WO2012175481A1 Compositions and methods for treating leukemia
12/27/2012WO2012154122A3 A topical formulation for treatment of hyperkeratotic skin
12/27/2012WO2012141796A3 Prostate cancer therapy with hsp90 inhibitory compounds
12/27/2012WO2011159770A3 Methods and compositions for promoting hair growth
12/27/2012US20120330019 Hepatitis C Virus Inhibitors
12/27/2012US20120329844 Valsartan salts
12/27/2012US20120329781 Combinations comprising alpha-2-delta ligands
12/27/2012US20120329765 Medicinal targeted local lipolysis
12/27/2012US20120329750 Method for producing purified hematinic iron-saccharidic complex and product produced
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329153 Car receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120328700 Methods and compositions for regenerating connective tissue
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328573 Composition for Maintaining Healthy Kidney Function
12/27/2012CA2841203A1 Apoptosis-inducing agent
12/26/2012EP2537524A2 Treatment of T-cell mediated diseases
12/26/2012EP2537521A1 Unit dosage for brain health
12/26/2012EP2537416A1 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
12/26/2012EP2536748A1 Neuregulin antagonists and use thereof in treating cancer
12/26/2012EP2536415A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures
12/26/2012EP2536411A2 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
12/26/2012EP2536402A1 Compositions comprising amphetamin and lisdexamfetamine
12/26/2012EP2536400A1 Pharmaceutical comprising myramistin
12/26/2012EP2536293A1 Methods and compositions for use in aquaculture
12/26/2012CN102844033A Methods and compositions for improving implant osseointegration
12/26/2012CN102844026A Fungal nail treatment composition
12/26/2012CN102844024A Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
12/26/2012CN102844022A Local anesthetic emulsion compositions and methods of making and using the same
12/26/2012CN102841200A Use of pIgR as molecular marker of early recurrence and/or metastasis of tumor and intervening target spot of anti-tumor metastasizing medicine
12/26/2012CN102836446A In-vivo phase transition tumor targeted nanobubble, its preparation method and application
12/26/2012CN102836438A Multi-component biological transport systems
12/26/2012CN102836433A Sensitizing agent used for reversing or reducing esophageal cancer radiotherapy resistance, screening method thereof, and purpose thereof
12/26/2012CN102836432A Nasal preparation for treating epilepsy
12/26/2012CN101553214B Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
12/26/2012CN101484187B Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
12/25/2012US8338396 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
12/25/2012US8338376 Compositions comprising variant LT-B-R-IG fusion proteins
12/25/2012US8338373 Method for reducing the risk of spontaneous abortion in a human female subject
12/25/2012US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof
12/25/2012US8338137 Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strains
12/25/2012US8337887 Rapidly disintegrating taste-masked tablet
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337833 Methods of improving central nervous system functioning
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012171793A1 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
12/20/2012WO2012171621A1 Pharmaceutical preparation for treating infections of the intestine with ehec bacteria
12/20/2012WO2012171364A1 Oil-soluble pharmaceutical composition
12/20/2012US20120323273 High strength suture with absorbable core and suture anchor combination
12/20/2012US20120323162 Methods and Compositions for Treating Conditions of the Eye
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322777 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
12/20/2012US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer
12/20/2012US20120322105 Growth factor
12/20/2012US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof
12/20/2012US20120321597 Methods and compositions for regenerating connective tissue
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/19/2012EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
12/19/2012EP2535047A1 Nutritional composition, food supplement comprising said nutritional composition and kit comprising said food supplement
12/19/2012EP2534150A2 Methods of treating viral infection
12/19/2012EP2533793A2 Compositions and uses of lectins
12/19/2012EP2533779A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase
12/19/2012EP2533778A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
12/19/2012EP2533645A1 Methods and compositions for improving cognitive function
12/19/2012CN1636229B Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response
12/19/2012CN102834512A Metal salen complex derivative and process for production thereof
12/19/2012CN102834115A Recombinant human CC10 protein for treatment of influenza
12/19/2012CN102834092A Transdermally absorbed preparation of anti-dementia drug
12/19/2012CN102827265A Novel gene of sorting nexin (SNX) family and use thereof
12/19/2012CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
12/19/2012CN102824660A Peritoneal dialysis solution
12/19/2012CN102824639A Emergency solution used for relieving burn of hydrofluoric acid
12/19/2012CN102824638A Medicinal composition containing zafirlukast and statins
12/19/2012CN102824637A Application of TRPC5 as drug target in reversing multi-drug resistance
12/19/2012CN102824636A Pharmaceutical composition containing statins and polyunsaturated fatty acid and application thereof
12/19/2012CN101495148B Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
12/18/2012US8334263 Analgesic methods and compositions
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8334248 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
12/18/2012US8333992 Gastric retained gabapentin dosage form
12/18/2012US8333991 Gastric retained gabapentin dosage form
12/18/2012US8333983 Drug delivery system
12/18/2012US8333959 Ex-vivo application of solid microparticulate therapeutic agents
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 1151